Stifel Financial Corp Matinas Bio Pharma Holdings, Inc. Transaction History

Stifel Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.67 - $1.51 $54,270 - $122,310	-81,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$0.96 - $1.74 $26,716 - $48,424	27,830 Added 52.34%	81,000 $85,000
Q4 2020 Feb 12, 2021	SELL	$0.76 - $1.47 $1,555 - $3,009	-2,047 Reduced 3.71%	53,170 $72,000
Q3 2020 Nov 16, 2020	BUY	$0.67 - $0.96 $13,400 - $19,200	20,000 Added 56.79%	55,217 $42,000
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $2,147 - $3,798	-4,129 Reduced 10.49%	35,217 $27,000
Q1 2020 May 14, 2020	BUY	$0.6 - $2.31 $2,607 - $10,039	4,346 Added 12.42%	39,346 $24,000
Q4 2019 Feb 13, 2020	BUY	$0.63 - $2.27 $22,050 - $79,450	35,000 New	35,000 $78,000

2.74M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $139M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.